Concepedia

Publication | Open Access

Phase I, First-in-Human Study of the Probody Therapeutic CX-2029 in Adults with Advanced Solid Tumor Malignancies

DOIFull Paper Access

56

Citations

18

References

2021

Year

Melissa L. Johnson, Anthony B. El-Khoueiry, Navid Hafez, Nehal J. Lakhani, Hirva Mamdani, Jordi Rodón, Rachel E. Sanborn, Javier Garciá Corbacho, Valentina Boni, Mark Stroh,
Clinical Cancer Research

Abstract

The Probody therapeutic platform enables targeting CD71, a previously undruggable ADC target, at tolerable doses associated with clinical activity.<i>See related commentary by Oberoi and Garralda, p. 4459</i>.

References

YearCitations

Page 1